TGA warns about capsule interactions
Regulator says Grakcu can have dangerous interactions with other prescription medicines The Therapeutic Goods Administration (TGA) says Grakcu capsules can pose a “serious risk to health” and shouldn’t be taken by …
Brett MacFarlane joins the AJP
We welcome a leading pharmacist educator and writer onto our team Dr Brett MacFarlane BPharm (Hons), PhD, EFACP, MPS has been appointed to the new role of Clinical Editor and …
Allergic rhinitis: essential information for better patient care
Allergic rhinitis (AR) is common, affecting one in five Australians.1 AR not only affects wellbeing through bothersome nasal symptoms, but also impacts quality of life.2 Professor Richard Harvey, (Rhinologist, ENT …
Natural ingredients for acute dry and productive coughs
This article examines the pathophysiology of acute cough, the transition from dry to productive presentations, and the evidence for nine natural ingredients used in combination cough formulations. By Dr Brett …
Topical management of mild acne: understanding the role of salicylic acid
This article explores the pathophysiology and clinical presentation of acne vulgaris, how to identify patient suitability for pharmacy-based management, and evidence-based treatment options, focusing on the role of salicylic acid …
The gut–brain axis and probiotic applications
This article will help pharmacists understand how the gut microbiome communicates with the central nervous system, outlining current probiotic research and the latest insights into how microbes influence brain function. …
Passing comment—or professional risk?
USING THE PDL RISK MANAGEMENT GUIDE FOR PHARMACISTS This series introduces pharmacists to the PDL Risk Management Guide for Pharmacists, and how it can be used in everyday pharmacy practice …